GC Biopharma Corp (GC Biopharma), formerly known as GC Pharma, is a biopharmaceutical company that focuses on the development, manufacture, and distribution of a wide range of pharmaceutical products.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company’s R&D activities are focused on developing plasma derivatives, recombinants, cell therapies, and vaccines for the treatment of Hemophilia A and B, hunter syndrome, oncology, immunology, cell Therapy, and other diseases. The company’s major product line which is in PhaseIII includes GC5101B for congenital immunodeficiency and immune thrombocytopenia; GC5107B for primary immunodeficiency; MGAH22 to treat breast cancer; and GC3107A for the treatment of tuberculosis. Its Phase II product line includes GC1111B for Hunter Syndrome; GC1118A for colorectal cancer; GC1109 to treat anthrax; GC3111A for Tetanus, diphtheria, whooping cough; GC3114A for seasonal flu; and MG4101 for hepatocellular carcinoma. GC Biopharma conducts its R&D activities at a global R&D center located in Yongin, Gyeonggi, South Korea. In FY2022, the company spent KRW191,300 million on its R&D activities an increase of 31% from FY2022, which accounted for 11.2% of the company’s total revenue. The company works in partnerships and research collaborations with biotechnology start-ups, universities, research organizations, academia, and global leading companies to develop new drug candidates.